ARTICLE | Clinical News

GCS-100LE: Phase I/II started

April 11, 2005 7:00 AM UTC

GLGS began a U.S. Phase I/II trial. Patients will receive 2 doses of the compound for 2 weeks followed by an off week. Dexamethasone may be added if patients progress after 2 cycles or remain stable a...